期刊文献+

二甲双胍在治疗胰岛素抵抗多囊卵巢综合征中的作用探讨

Metformin in Treatment of Insulin-resistance in PCOS
下载PDF
导出
摘要 目的分析3种方案对胰岛素抵抗多囊卵巢综合征(PCOS)患者的促排卵结局,探讨二甲双胍对胰岛素抵抗PCOS患者的应用价值及其作用机制。方法将100例胰岛素抵抗PCOS患者随机分为A,B,C3组。A组34例用Diane-35治疗3个周期后用CC+HMG促排卵;B组35例用二甲双胍治疗3个月后用CC+HMG促排卵;C组31倒应用Diane-35加二甲双胍治疗3个月后用CC+HMG促排卵。观察3组病人治疗前后的BMI,T,FINS,TNF-α及排卵率。结果3组病人治行后BMI及T差异无显著性(P>0.05);A组较B,C两组FINS,TNF-α及排卵率差异有显著性(P<0.05)。结论胰岛素抵抗PCOS患者治疗的关键在于应用胰岛素增敏剂降低FINS,Diane-35虽可降低血T,但促排卵结局并不理想。 Objective To analyze the effects of the three ovulation progrants on the treatment of insulin-resisting (IR)patients with polycystic ovary syndrome (PCOS),and investigate kthe applicable value and the reason of impact of metformin as well.Methods One hundred insulin-resisting cases with PCOS were divided into therr groups randomly.Patients in group A(n=34)were given Diane-35 for three eycles and then were given Clomiphene citrate (CC)plus HMG.Group B(n=35) were given metformin for three mouths and then were given CCplus HMG.Group C(n=31) were treated with Diane-35 and metformin for three months and then were treated with CC and HMG.The BMI,T,FINS,TNF-αand ovulation rate of the patients in the three groups were observed and studied before and after treatment .Results There was no obvious difference in the aspects of BMI and testosterone (T) after treatment in the three groups (P〉0.05);Whereas the FINS,TNF-αand the ovulation rate in group A were significant different (P〈0.05)from those in group B and C.Conclusion The key of the treatment for the IR patients with PCOS is to use the drug which can increase the sensitivity of insulin to decrease the FINS Diane-35 can reduce the level of T,but the effects of ovulation rate are not satisfied.
出处 《潍坊医学院学报》 2005年第5期321-323,共3页 Acta Academiae Medicinae Weifang
关键词 二甲双胍 胰岛素抵抗 多囊卵巢综合征 促排卵 Metformin Insulin-resistance Polycysitc ovary syndrome Ovulaiton
  • 相关文献

参考文献9

  • 1姜艳华,李晓辉,李美芝.多囊卵巢综合征胰岛素抵抗患者的临床特征[J].实用妇产科杂志,2001,17(5):293-294. 被引量:17
  • 2王颖,李美芝,赵一鸣.预测多囊卵巢综合征促排卵治疗结局的研究[J].中华妇产科杂志,2000,35(10):594-596. 被引量:12
  • 3Qin KN,Rosenfield RL.Role of cytochrone P450c17 in polycystic ovary syndrone[J].Mol Cell Endocrinel,1998,145(2):111~121. 被引量:1
  • 4Ruil,Aguirrev,Kim JK,et al.Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 inhibitory Ser307 Via distinct pathways[J].J Clin Invest,2001,107(2):181~189. 被引量:1
  • 5Oakes ND,Camilleris,Furlersm,et al.The insulin sensitizer,BRL49653,reduces systemic fatty acid supply and utilization and lipid availability[J].Metabolism,1997,46(8):935~937. 被引量:1
  • 6叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2001.824. 被引量:267
  • 7Velazquez E,Acosta A,Mendoza SG.Menstrual cyclicity after metformin therapy in polycystic ovary syndrome[J].Obster Gynecol,1997,90(3):392~393. 被引量:1
  • 8Elter K,Imir G,Durmusoglu F.Clinical endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome:a randomized controlled study[J].Hum Reprod,2002,17(7):1 729~1 737. 被引量:1
  • 9Ibanez L,De Zeghrt F.Low-dose combination of flutamide,metformin and an oral contraceptive for non-obese,young women with polycystic ovary syndrome[J].Hum Reprod,2003,18(1):57~60. 被引量:1

二级参考文献4

共引文献292

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部